Skip to content
← Full study record

NCT00335738 · MORE INFO

Limitations, agreements, and source contact

Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma · Source last updated 2021-02-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
Must obtain prior Sponsor approval.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
limitations And Caveats
description
The COG SDC reviewed the NLM notification related to ct.gov AE/SAE reporting. The information in 'Additional Description' is accurate with respect to data supplied to ct.gov.COG plans to submit data AE/SAE data consistent with the text in this field.
point Of Contact
email
resultsreportingcoordinator@childrensoncologygroup.org
organization
Children's Oncology Group
phone
352-273-0567
title
Results Reporting Coordinator
Complete source fields
certain Agreement
other Details
Must obtain prior Sponsor approval.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
limitations And Caveats
description
The COG SDC reviewed the NLM notification related to ct.gov AE/SAE reporting. The information in 'Additional Description' is accurate with respect to data supplied to ct.gov.COG plans to submit data AE/SAE data consistent with the text in this field.
point Of Contact
email
resultsreportingcoordinator@childrensoncologygroup.org
organization
Children's Oncology Group
phone
352-273-0567
title
Results Reporting Coordinator

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice